Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

798 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Brain-derived neurotrophic factor in Huntington disease.
Ferrer I, Goutan E, Marín C, Rey MJ, Ribalta T. Ferrer I, et al. Brain Res. 2000 Jun 2;866(1-2):257-61. doi: 10.1016/s0006-8993(00)02237-x. Brain Res. 2000. PMID: 10825501
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways.
Bové J, Serrats J, Mengod G, Cortés R, Tolosa E, Marin C. Bové J, et al. Exp Brain Res. 2005 Sep;165(3):362-74. doi: 10.1007/s00221-005-2302-1. Epub 2005 Jun 21. Exp Brain Res. 2005. PMID: 15968457
BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.
Ferrer I, Marín C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Martí E. Ferrer I, et al. J Neuropathol Exp Neurol. 1999 Jul;58(7):729-39. doi: 10.1097/00005072-199907000-00007. J Neuropathol Exp Neurol. 1999. PMID: 10411343
Brain-derived neurotrophic factor in patients with frontotemporal dementia.
Ferrer I, Marín C, Rey MJ, Ribalta T. Ferrer I, et al. Neurosci Lett. 2000 Jan 21;279(1):33-6. doi: 10.1016/s0304-3940(99)00937-4. Neurosci Lett. 2000. PMID: 10670781
SCH 23390-induced behavioral supersensitivity is not related to striatal c-fos levels.
Muñoz JE, Marín C, Tolosa E. Muñoz JE, et al. Brain Res. 1997 Nov 7;774(1-2):51-4. doi: 10.1016/s0006-8993(97)81686-1. Brain Res. 1997. PMID: 9452191
SCH 23390 treatment (0.5 mg/kg/day) for 21 days increased both apomorphine-induced orofacial stereotypies and striatal c-fos levels. ...These findings suggest that SCH 23390-induced behavioral supersensitivity and the increased striatal c-fos levels are concomitant …
SCH 23390 treatment (0.5 mg/kg/day) for 21 days increased both apomorphine-induced orofacial stereotypies and striatal c-fos levels. …
Effect of long-term haloperidol treatment on striatal neuropeptides: relation to stereotyped behavior.
Marin C, Engber TM, Bonastre M, Chase TN, Tolosa E. Marin C, et al. Brain Res. 1996 Aug 26;731(1-2):57-62. doi: 10.1016/0006-8993(96)00461-1. Brain Res. 1996. PMID: 8883854
Rats, given haloperidol (1 mg/kg, i.c.) for 21 consecutive days, were randomly allocated to one of the following treatments: the D1 agonist SKF 38393, the D2 agonist quinpirole, their combination or saline. ...
Rats, given haloperidol (1 mg/kg, i.c.) for 21 consecutive days, were randomly allocated to one of the following treatments: the D1 a …
Nuclear factor kappa-B p50 and p65 subunits expression in dementia with Lewy bodies.
Saldaña M, Mullol J, Aguilar E, Bonastre M, Marin C. Saldaña M, et al. Neuropathol Appl Neurobiol. 2007 Jun;33(3):308-16. doi: 10.1111/j.1365-2990.2007.00806.x. Epub 2007 Apr 18. Neuropathol Appl Neurobiol. 2007. PMID: 17442064
Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.
Jiménez A, Bonastre M, Aguilar E, Marin C. Jiménez A, et al. Psychopharmacology (Berl). 2009 Oct;206(2):233-42. doi: 10.1007/s00213-009-1600-x. Epub 2009 Jul 28. Psychopharmacology (Berl). 2009. PMID: 19636538
Striatal expression of tyrosine hydroxylase (TH), Homer 1a, 1b/c, and deltaFosB were measured by Western Blot. RESULTS: Animals treated with levodopa showed an increase of dyskinesia score (p<0.01) that was attenuated by the administration of MPEP (p<0.01). ...No sig …
Striatal expression of tyrosine hydroxylase (TH), Homer 1a, 1b/c, and deltaFosB were measured by Western Blot. RESULTS: Animals treat …
798 results
Jump to page
Feedback